Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
Top Cited Papers
Open Access
- 24 March 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1470-1477
- https://doi.org/10.1016/j.kint.2021.03.009
Abstract
No abstract availableFunding Information
- Imperial College Healthcare NHS Trust
- Imperial College London
- National Institute for Health Research
This publication has 31 references indexed in Scilit:
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19The New England Journal of Medicine, 2020
- The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsScience Immunology, 2020
- Epidemiology of COVID-19 in an Urban Dialysis CenterJournal of the American Society of Nephrology, 2020
- Presentation and Outcomes of Patients with ESKD and COVID-19Journal of the American Society of Nephrology, 2020
- Vaccinating the Patient with ESKDClinical Journal of the American Society of Nephrology, 2019
- Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney diseasePLOS ONE, 2018
- Previous Vaccination and Age are More Important Predictors of Immune Response to Influenza Vaccine than Inflammation and Iron Status in Dialysis PatientsKidney and Blood Pressure Research, 2016
- Immune cell dysfunction and inflammation in end-stage renal diseaseNature Reviews Nephrology, 2013
- Uremia causes premature ageing of the T cell compartment in end-stage renal disease patientsImmunity & Ageing, 2012
- Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to Respiratory Epithelium in a Viral Species- and Cell Type-Dependent MannerJournal of Virology, 2006